Blog

Categories
  1. Lung cancer

    Researchers are suggesting that metastatic tumours in the lung can be successfully eradicated using cryotherapy – literally turning the masses into ice balls that are then resorbed by the body.
    Industry news

    Read more »
  2. Biosimilars

    The FDA has approved the first biosimilar for the treatment of certain breast and stomach cancers.
    Industry news

    Read more »
  3. Multiple Sclerosis

    Mavenclad (cladribine) has become the multiple sclerosis therapy of choice for 1 in 5 neurologists in Germany and the UK. Meanwhile, many European neurologists wait for Ocrevus (ocrelizumab).
    Industry news

    Read more »
  4. Lung cancer

    A phase 3 study on lung cancer showed that Imfinzi (durvalumab) as a consolidation therapy reduced the risk of the disease progressing by 48 percent.
    Industry news

    Read more »
  5. HIV/AIDS

    FDA approves Juluca (dolutegravir and rilpivirine) for the maintenance treatment of certain patients with HIV-1 infection.
    Industry news

    Read more »
  6. A new medicine for Alzheimer's disease?

    Introducing a breakthrough known as 'CT1812'

    alzheimer disease

    Read more »
  7. Defining ocrelizumab's role within the MS treatment landscape

    Ocrevus (ocrelizumab) was approved in the US by the FDA in March 2017 for the treatment of adults with relapsing or primary progressive forms of MS, based on three clinical trials.

    ocrelizumab MS treatment

    Read more »
  8. Edaravone availability in the US - one month to go

    As we await the arrival of edaravone to US pharmacies, patients can access edaravone now through TheSocialMedwork.edaravone best price

    Read more »
  9. PrEP for HIV Prevention

    With recent drops in new HIV diagnoses being linked to buying PrEP through online buyers clubs, the addition of PrEP to the WHO's essential medicine list, and the recent approval of generic PrEP in the US - here’s what you need to know.

    PrEP for HIV Prevention

    Read more »
  10. Another high price tag for Duchenne muscular dystrophy treatment

    PTC Therapeutics announce the launch of Emflaza for the treatment of Duchenne muscular dystrophy (DMD) within the coming weeks, with an expected net price of $35,000.

    Read more »
  11. Accessing edaravone in your country - the new FDA approved drug for ALS

    What are the results from the clinical studies that led to the approval of edaravone, and how can patients access it in their country?

    edaravone FDA ALS

    Read more »
  12. Radicava/Radicut (edaravone) for ALS

    For the first time in 22 years, the US Food and Drug Administration (FDA) has approved a drug to treat patients with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease; a motor neuron disease characterised by muscular atrophy and weakness.
    Radicava Radicut edaravone ALS

    Read more »
  13. The pricing controversy surrounding Duchenne muscular dystrophy (DMD) treatment

    The latest events surrounding the pricing of a Duchenne muscular dystrophy (DMD) treatment

     Duchenne muscular dystrophy (DMD) treatment price

    Read more »
  14. Australia’s Pharmaceutical Benefits Scheme (PBS) announce new treatments and price cuts for over 1000 medications

    The PBS, Australia’s national program responsible for providing subsidised prescriptions, has announced the addition of several new medicines

    globe Australia

    Read more »
  15. Nivolumab Dominates the News

    Promising Results from Multiple Studies

    nivolumab news

    Read more »
  16. Daratumumab approved as multiple myeloma treatment

    The FDA approval of a promising new drug is offering new hope to multiple myeloma patients who have already been through various treatments. 

    Daratumumab multiple myeloma treatment

    Read more »
  17. Alectinib approved for the treatment of ALK-positive NSCLC

    A new treatment that targets a specific type of lung cancer has received FDA approval. 

    Alectinib treatment ALK-positive NSCLC

    Read more »
  18. Jimmy Carter’s cancer remission highlights the power of pembrolizumab

    On Sunday former US president and Nobel Peace Prize laureate proclaimed to a Sunday school class that he is cancer-free.

    Jimmy Carter cancer

    Read more »
  19. Edaravone approved in Japan for the treatment of ALS

    The Pharmaceutical and Medical Device Agency (PMDA), has granted marketing approval for the use of Edaravone for the treatment of ALS in Japan.

    Man in a wheelchair

    Read more »
  20. Promising results for cancer-immunotherapies revealed!

    Impressive results have been published last week regarding two new immunotherapies. 

    Lab Image

    Read more »
Page
US United States 0